Understanding Follicular Output Rate (FORT) and its Implications for POSEIDON Criteria by Michael Grynberg, Michael Grynberg, Michael Grynberg, Michael Grynberg, Julie Labrosse

Get full text

Anti-Müllerian Hormone in Fertility Preservation: Clinical and Therapeutic Applications by Charlotte Sonigo, Isabelle Beau, Nadine Binart, Michael Grynberg

Get full text

Impact of legislation and public funding on oncofertility: a survey of Canadian, French and Moroccan pediatric hematologists/oncologists by Aliya Oulaya Affdal, Michael Grynberg, Laila Hessissen, Vardit Ravitsky

Get full text

Does a web-based decision aid improve informed choice for fertility preservation in women with breast cancer (DECISIF)? Study protocol for a randomised controlled trial by Alexandra Benoit, Michael Grynberg, Rémy Morello, Nathalie Sermondade, Guillaume Grandazzi, Grégoire Moutel

Get full text

Psychosocial and professional burden of Medically Assisted Reproduction (MAR): Results from a French survey. by Blandine Courbiere, Arnaud Lacan, Michael Grynberg, Anne Grelat, Virginie Rio, Elisangela Arbo, Céline Solignac

Get full text

Comparison of GnRH agonist and hCG for priming in vitro maturation cycles in cancer patients undergoing urgent fertility preservation. by Hady El Hachem, Charlotte Sonigo, Julie Benard, Marion Presse, Christophe Sifer, Nathalie Sermondade, Michael Grynberg

Get full text

Growth development of French children born after in vitro maturation. by Laurence Foix-L'Hélias, Michael Grynberg, Béatrice Ducot, Nelly Frydman, Violaine Kerbrat, Jean Bouyer, Philippe Labrune

Get full text

Serous Borderline Ovarian Tumor Diagnosis, Management and Fertility Preservation in Young Women by Marie Carbonnel, Laetitia Layoun, Marine Poulain, Morgan Tourne, Rouba Murtada, Michael Grynberg, Anis Feki, Jean Marc Ayoubi

Get full text

Age as A Predictor of Embryo Quality Regardless of The Quantitative Ovarian Response by Juliano Brum. Scheffer, Bruno Brum. Scheffer, Rafaela Friche de Carvalho, Joyce Rodrigues, Michael Grynberg, Daniel H. Mendez Lozano

Get full text

Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger... by Imane Lalami, Julie Labrosse, Isabelle Cedrin-Durnerin, Marjorie Comtet, Claire Vinolas, Fabien Krief, Christophe Sifer, Maeliss Peigne, Michael Grynberg

Get full text

Dysfunction of Human Estrogen Signaling as a Novel Molecular Signature of Polycystic Ovary Syndrome by Clémentine Marie, Alice Pierre, Anne Mayeur, Frank Giton, Raphael Corre, Michaël Grynberg, Joëlle Cohen-Tannoudji, Céline J. Guigon, Stéphanie Chauvin

Get full text

Estradiol Regulates mRNA Levels of Estrogen Receptor Beta 4 and Beta 5 Isoforms and Modulates Human Granulosa Cell Apoptosis by Alice Pierre, Anne Mayeur, Clémentine Marie, Victoria Cluzet, Jonathan Chauvin, Nelly Frydman, Michael Grynberg, Joelle Cohen-Tannoudji, Céline J. Guigon, Stéphanie Chauvin

Get full text

Should Preimplantation Genetic Testing (PGT) Systematically Be Proposed to <i>BRCA</i> Pathogenic Variant Carriers? by Lucie Laot, Charlotte Sonigo, Julie Nobre, Alexandra Benachi, Traicie Dervin, Lina El Moujahed, Anne Mayeur, Dominique Stoppa-Lyonnet, Julie Steffann, Michael Grynberg

Get full text

Response to Ovarian Stimulation for Urgent Fertility Preservation before Gonadotoxic Treatment in <i>BRCA</i>-Pathogenic-Variant-Positive Breast Cancer Patients by Lina El Moujahed, Robin Philis, Michael Grynberg, Lucie Laot, Pauline Mur, Noemi Amsellem, Anne Mayeur, Alexandra Benoit, Sophia Rakrouki, Christophe Sifer, Maeliss Peigné, Charlotte Sonigo

Get full text

Factors Associated With the Discussion of Fertility Preservation in a Cohort of 1,357 Young Breast Cancer Patients Receiving Chemotherapy by Alice Hours, Aullene Toussaint, Aullene Toussaint, Aullene Toussaint, Victoire De Castelbajac, Victoire De Castelbajac, Camille Sautter, Julie Borghese, Sophie Frank, Florence Coussy, Enora Laas, Enora Laas, Beatriz Grandal, Elise Dumas, Eric Daoud, Julien Guerin, Thomas Balezeau, Jean-Guillaume Feron, Virginie Fourchotte, Youlia Kirova, Florence Lerebours, Jean-Yves Pierga, Eugénie Guillot, Pietro Santulli, Michael Grynberg, Michael Grynberg, Charlotte Sonigo, Emmanuel Reyrat, Pauline Soibinet-Oudot, Fabien Reyal, Fabien Reyal, Anne-Sophie Hamy, Anne-Sophie Hamy, Anne-Sophie Hamy

Get full text

Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus by Raoul Orvieto, Raoul Orvieto, Raoul Orvieto, Christos A. Venetis, Christos A. Venetis, Human M. Fatemi, Thomas D’Hooghe, Thomas D’Hooghe, Thomas D’Hooghe, Robert Fischer, Yulia Koloda, Yulia Koloda, Marcos Horton, Michael Grynberg, Salvatore Longobardi, Sandro C. Esteves, Sandro C. Esteves, Sesh K. Sunkara, Yuan Li, Carlo Alviggi

Get full text

The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists by Sandro C. Esteves, Carlo Alviggi, Peter Humaidan, Peter Humaidan, Robert Fischer, Claus Y. Andersen, Alessandro Conforti, Klaus Bühler, Klaus Bühler, Sesh K. Sunkara, Nikolaos P. Polyzos, Daniela Galliano, Michael Grynberg, Hakan Yarali, Irem Y. Özbek, Matheus Roque, Lan N. Vuong, Lan N. Vuong, Manish Banker, Laura Rienzi, Alberto Vaiarelli, Danilo Cimadomo, Filippo M. Ubaldi

Get full text

COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management by Carlo Alviggi, Sandro C. Esteves, Raoul Orvieto, Alessandro Conforti, Antonio La Marca, Robert Fischer, Claus Y. Andersen, Klaus Bühler, Sesh K. Sunkara, Nikolaos P. Polyzos, Ida Strina, Luigi Carbone, Fabiola C. Bento, Daniela Galliano, Hakan Yarali, Lan N. Vuong, Michael Grynberg, Panagiotis Drakopoulos, Pedro Xavier, Joaquin Llacer, Fernando Neuspiller, Marcos Horton, Matheus Roque, Evangelos Papanikolaou, Manish Banker, Michael H. Dahan, Shu Foong, Herman Tournaye, Christophe Blockeel, Alberto Vaiarelli, Peter Humaidan, Filippo M. Ubaldi, on behalf of the POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) group

Get full text